BeStock  
Markets › Compare › INSM vs ALNY

INSM vs ALNY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
INSM · Insmed$110.96 ▼ 2.79%
ALNY · Alnylam Pharmaceuticals$235.60 ▼ 4.51%

Head to head

MetricINSMALNY
Price$110.96$235.60
Change today▼ 2.79%▼ 4.51%
Market cap$24.23B$31.53B
Return, 3 months+3.7%–
Return, year to date-36.2%–
Return, 1 year-24.7%–
P/E (TTM)-26.941.0
P/B32.023.3
P/E percentile vs own 5y8th84th
Dividend yield––
Revenue growth (YoY, latest qtr)+296.1%+66.9%
Net profit growth (YoY)+95.9%+327.7%
Gross margin83.5%79.7%
Operating margin-71.4%20.8%
Net margin-76.9%16.1%
Return on equity-87.2%96.6%
Analyst target vs. price+78.6%+57.0%
Analyst buy share100%86%
RSI (14)39–
30-day volatility35.4%–
Max drawdown, 1 year-56.5%–
Trend readStrong downtrend–
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ALNY is the largest of the group by market value.
  • INSM carries the lowest trailing P/E.
  • INSM is growing revenue fastest.
  • ALNY keeps the most profit per dollar of sales.

Go deeper

Scroll to Top